New Treatment for Rheumatoid Arthritis

FDA Regulators in November approved Pfizer’s Xeljanz treatment for rheumatoid arthritis, which is now poised to compete with Abbott Laboratories’ top-selling Humira. Pfizer’s pill is for patients with moderate to severe rheumatoid arthritis who did not benefit from or were unable to tolerate the standard oral treatment, methotrexate. Xeljanz can be used by itself or in combination with methotrexate and certain other treatments.

The F.D.A. approved a 5-milligram dose of Xeljanz, given twice a day. The agency said further safety data was needed to assess a 10-milligram, twice-daily dose, that Pfizer had also put before regulators.

 

William Wombacher, your Central Illinois Certified Elder Law Attorney (CELA) and Social Security Disability Specialist. I’ll help you!   www..wombacherlaw.com
Serving Peoria, East Peoria, Peoria Heights, Pekin, Dunlap, Chillicothe, Morton, Washington, Metamora, Canton, Galesburg, Bloomington, Normal and surrounding cites and counties of Peoria, Tazewell, Woodford, Fulton and  Knox Counties in Central Illinois.

I Make Home &
Hospital Visits

Schedule A
Free Consult

Let Me Help

The Law Office of William C. Wombacher

Local: 309-674-8125
Toll Free: 888-365-0852
Fax: 309-674-8149

Commerce Bank Building
416 Main Street Suite 700
Peoria, IL 61602
Icon Facebook
Logo Nelf
Logo Cap Naela
Logo Nosscr
Best Probate Attorneys in Peoria
Illinois State Bar Association